Our findings show that chronic exposure to BMAA can trigger Alzheimer’s-like brain tangles and amyloid deposits. As far as we are aware, this is the first time researchers have been able to successfully replicate brain tangles and amyloid deposits in an animal model through exposure to an environmental toxin.
— Paul Alan Cox, Ph.D., Executive Director.

Utilizing indigenous knowledge and a radically different approach to drug research, Dr. Paul Cox and his team may have cracked the code to treating neurodegenerative brain disease.

Produced & Edited by Jesse Rogala.

Dr Sandra Banack talks about the development of the ALS biomarker.